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Sarah L. Newton,a Richard B. Gillis,bc Gary G. Adams,bc Arthur J. Rowe,b
Stephen E. Harding,b Melanie M. Brittona and Anna F. A. Peacock*a
Herein, we establish for the ﬁrst time the design principles for lanthanide coordination within coiled coils,
and the important consequences of binding site translation. By interrogating design requirements and by
systematically translating binding site residues, one can inﬂuence coiled coil stability and more
importantly, the lanthanide coordination chemistry. A 10 A˚ binding site translation along a coiled coil,
transforms a coordinatively saturated Tb(Asp)3(Asn)3 site into one in which three exogenous water
molecules are coordinated, and in which the Asn layer is no longer essential for binding, Tb(Asp)3(H2O)3.
This has a profound impact on the relaxivity of the analogous Gd(III) coiled coil, with more than a four-
fold increase in the transverse relaxivity (21 to 89 mM1 s1), by bringing into play, in addition to the
outer sphere mechanism present for all Gd(III) coiled coils, an inner sphere mechanism. Not only do
these ﬁndings warrant further investigation for possible exploitation as MRI contrast agents, but
understanding the impact of binding site translation on coordination chemistry has important
repercussions for metal binding site design, taking us an important step closer to the predictable and
truly de novo design of metal binding sites, for new functional applications.Introduction
Metal ions are essential in many biological processes, with an
estimated one third of all proteins requiring a metal ion to
function.1 However, despite the extensive use of metal ions in
biology, nature selects from a rather limited range. This likely
reects their “bio-availability”, with metal ions buried deep in
the earth's crust being unlikely candidates, but it does allow one
to contemplate, what type of chemistry might the inclusion of
non-biological or xeno metal ions, allow biology to achieve.
Not surprisingly, a number of examples exist in which either
the native metal ion is replaced with a xeno metal, or alterna-
tively, a new site is specically engineered into a biomolecule
for subsequent xeno metal binding. Notable examples of rele-
vance to this work involve the introduction of lanthanide metal
ions, with no known biological role, for their attractiveam, Edgbaston, B15 2TT, UK. E-mail: a.f.
ydrodynamics, School of Biosciences,
, LE12 5RD, UK
of Nottingham, Queen's Medical Centre,
(ESI) available: Methods, peptide
spectrometry and analytical HPLC,
r dichroism, luminescence, and NMR
hemistry 2016magnetic and photophysical properties. For example, lantha-
nide-binding tags (LBTs) have been developed, commonly
inspired by native calcium binding sites, for introduction into
protein sequences. Their high aﬃnity for lanthanide ions allows
for their use as luminescent probes to solve protein dynamics,
structural restraints and distancing in NMR, as well as potential
applications as MRI contrast agents.2–5
Rather than changing the metal, there has been much
interest in replacing native protein ligands with miniature
articial protein scaﬀolds, oen designed de novo (from rst-
principles). The fact that they represent much simpler systems
with which to establish important structure–function relation-
ships, make them attractive for exploitation. The large majority
of de novo peptides used for metal ion coordination, have
focused on the coiled coil, a supercoil of a-helices, which can be
designed predictably.6–9 Notable achievements include the
successful reproduction of biologically relevant mononuclear
sites, such as the active site of carbonic anhydrase,10 dinuclear
complexes, including dioxygen-activating di-iron sites,11 multi-
nuclear clusters, e.g. the cubane-like [4Fe–4S] cluster,12 and
introduction of inorganic cofactors such as the dioxygen
binding heme.13 Importantly, these metallocoiled coils can be
used to address key questions about native sites, and funda-
mental questions about metalloprotein coordination chemistry.
For example, Pecoraro and co-workers demonstrated that the
maximal rate, solvent/substrate access and metal bindingChem. Sci., 2016, 7, 2207–2216 | 2207
Table 1 Peptide sequences used in this study
Peptide Sequence
MB1-1 Ac-G IAANEWK DAAIEQK IAAIEQK IAAIEQK IAAIEQK G-NH2
MB1-2 Ac-G IAAIEQK IAANEWK DAAIEQK IAAIEQK IAAIEQK G-NH2
MB1-3 Ac-G IAAIEQK IAAIEQK IAANEWK DAAIEQK IAAIEQK G-NH2
MB1-4 Ac-G IAAIEQK IAAIEQK IAAIEQK IAANEWK DAAIEQK G-NH2
CS1-1 Ac-G IAAIEWK DAAIEQK IAAIEQK IAAIEQK IAAIEQK G-NH2
CS1-2 Ac-G IAAIEQK IAAIEWK DAAIEQK IAAIEQK IAAIEQK G-NH2
CS1-4 Ac-G IAAIEQK IAAIEQK IAAIEQK IAAIEWK DAAIEQK G-NH2
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View Article Onlineaﬃnity of the ZnHis3O carbonic anhydrase mimetic site, are
dependent on its location within the coiled coil.14
The large majority of de novo metallocoiled coil examples
have focused their eﬀorts onmimicking the active sites of native
metalloproteins, vide supra. However, our approach is to
combine both strategies and to develop articial proteins
complexed to xeno metals, with the view to developing new
functional systems for valuable applications beyond what can
be currently oﬀered by Nature (e.g. MRI contrast agents). Only
a few examples like these exist in the literature, and include
a designed three-stranded helical bundle capable of seques-
tering uranyl (UO2
2+) from seawater;15 as well as several short
reports of lanthanide coiled coils.16–18 We recently reported the
rst ever gadolinium coiled coil, interrogated its coordination
chemistry, and demonstrated, despite the lack of any inner
sphere water, its promising magnetic resonance contrast
capabilities.19
Our gadolinium binding site was engineered within the
hydrophobic core of a parallel three stranded coiled coil, based
on ve IaAbAcIdEeQfKg heptad repeats, by introducing an
aspartic acid (Asp, D) at an a site and an asparagine (Asn, N) in
the d site located directly above, so as to provide up to nine
O-donor ligands for lanthanide coordination. A tryptophan was
introduced adjacent to the binding site (at a f position), as its
ability to sensitize terbium emission allowed us to monitor and
probe terbium coordination directly. The resulting peptide,
MB1-2 (see Fig. 1B and Table 1), was found to fold in the
presence of trivalent lanthanide ions and bind coordinativelyFig. 1 Cartoon representation showing side-on views of (A) Ln(MB1-1)3, (
binding sites, including bound water molecules, shown at the bottom o
ribbons (green), the Asn, Asp and Trp side chains in stick form (oxygen i
2208 | Chem. Sci., 2016, 7, 2207–2216saturated terbium. Despite the lack of any coordinated water,
oen an important feature of gadolinium MRI contrast agents,
the Gd(MB1-2)3 complex displayed superior MRI relaxivity
(eﬃciency) when compared to Dotarem®, a small molecule
gadolinium complex currently used in the clinic.19
If these new classes of metallocoiled coils are to reach their
full potential as luminescent probes or MRI contrast agents, it is
vital to perform a systematic and rigorous study to identify the
essential design features for lanthanide coordination, and at
the same time, ways to optimize the design in terms of overall
stability and MRI relaxivity. Herein, we present a library of new
designs, with which we begin to address these issues. For the
rst time we demonstrate, by systematically moving the binding
site linearly along the coiled coil, that the metal coordination
chemistry, and in this case the associated luminescent, and
more strikingly the MRI properties, are all highly locationB) Ln(MB1-2)3, (C) Ln(MB1-3)3 and (D) Ln(MB1-4)3. Proposed models of
f the ﬁgure. Shown are the main chain atoms represented as helical
n red and nitrogen in blue), and the Ln(III) ion as a sphere (pink).
This journal is © The Royal Society of Chemistry 2016
Fig. 2 CD spectra of 30 mM MB1-1 (blue), MB1-2 (purple), MB1-3
(green) and MB1-4 (red) peptide monomer, in the absence (solid line)
and presence of 10 mMGdCl3 (dashed line), recorded at 293 K in 5 mM
HEPES buﬀer pH 7.0.
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View Article Onlinedependent. In fact translating the binding site 10 A˚, enhances
MRI relaxivity four-fold compared to our preliminary design,
Gd(MB1-2)3.19Results and discussion
Importance of binding site location along coiled coil
Our original design, MB1-2, features the designed lanthanide
binding site between the second and third heptad, however, on
closer inspection it is apparent that there are four distinct loca-
tions along the coiled coil, at which it could have been intro-
duced. The binding site could be moved up a heptad towards
the top (N-terminus of the coiled coil) to yield MB1-1, or down
one or two heptads (towards the C-terminus) to yield MB1-3 and
MB1-4, respectively (see Fig. 1 and Table 1). At rst glance it may
appear that the system is symmetrical, leading to two peptides
with Asn3Asp3 binding sites at the extremities of the coiled coil,
and two with binding sites locatedmore centrally. However, upon
closer inspection, and due to the spatial positioning of the
L-amino acid side chains, this is not the case, with for example,
the binding site in MB1-1 being located closer towards the coiled
coil terminus than in MB1-4, see Fig. 1. Furthermore, in the caseTable 2 Summary of % folded values, free energies of folding (DG

H2O
), bin
and relaxivity values (r1 and r2)
Apo-%
foldeda
Metallo-%
foldeda
Apo-DG

H2O/
kcal mol1
Metallo-DG

H2O
kcal mol1
MB1-1 80  6 83  7 20.8  3.5 22.4  1.5
MB1-2 21  3 62  3 12.7  1.5 15.3  2.0
MB1-3 15  1 41  4 — 16.7  3.9
MB1-4 55  6 70  5 16.3  2.6 19.3  4.8
a Data reported for 30 mM peptide monomer  10 mMGdCl3. Analogous da
(Table S1).
This journal is © The Royal Society of Chemistry 2016of MB1-1 the Asn layer is located more terminally (and more
exposed to solvent), whereas in MB1-4 this is instead the Asp
layer. So as to establish the importance of binding site location,
the complete series was prepared and studied.Location dependent coiled coil stability
The most striking diﬀerence between these isomeric coiled coils,
which consist of the same amino acids located in the same
heptad positions, is their diﬀerence in folding. A 30 mM solution
of MB1-3 monomer in 5 mM HEPES buﬀer pH 7.0, is similar,
though slightly less folded than MB1-2 (15  1 and 21  3%,
respectively), see Fig. 2 and Table 2. However, when the binding
site is translated closer towards the coiled coil terminus, the apo
peptides become increasingly more folded: 55  6% for MB1-4,
and 80  6% for MB1-1 which contains the most terminal
binding site. These ndings suggest that the binding site is more
tolerated towards the end of the coiled coil, where the ability
to expand and fray may be important in order to adjust and
accommodate the potentially bulky site. Furthermore, this
observation is consistent with a report that core heptads are
three times more stabilizing than N- or C-terminal heptads.20
Importantly, the CD spectra show an increase in folding on
addition of up to one equivalent of Gd(III) per trimer (there is no
substantial increase in folding above one equivalent), for all
four peptides, see Fig. 2 and S2,† consistent with retention of
Gd(III) binding regardless of binding site location. However,
a similar trend was observed with respect to peptide folding on
formation of Gd(MB1)3: Gd(MB1-3)3 is the least well folded
(41  4%), followed by Gd(MB1-2)3 (62  3%), with Gd(MB1-4)3
(70  5%) and Gd(MB1-1)3 (83  7%) being the most well fol-
ded, see Fig. 2, S2, Tables 2 and S1.†
In order to assess coiled coil stability, rather than simply the
extent of folding, both chemical and thermal denaturation
studies were performed and monitored by CD. The signal at
222 nm in the CD spectra (an indication of folding) of 30 mM
solutions of peptide monomers in 5 mM HEPES buﬀer pH 7.0,
were monitored with increasing urea concentration. Unfolding
curves were t to a two-state equilibrium model between folded
trimer and unfolded monomer (see Fig. S3†). The free energies
of folding in the absence of denaturant, DG

H2O, were deter-
mined in the absence and presence of Gd(III), see Table 2.
Though apo-MB1-3 could not be reliably t due to the lack ofding constant (log K), number of inner sphere water molecules (#H2O)
/
log KTb #H2O r1/mM
1 s1 r2/mM
1 s1
5.30  0.15 3.1  0.2 10.0  1.5 89.3  16.8
5.48  0.20 0.0  0.1 4.2  1.2 21.3  2.6
5.16  0.26 0.0  0.1 4.0  1.0 20.9  1.0
5.26  0.36 1.8  0.4 7.5  4.1 37.9  4.0
ta for 5 and 100 mM peptide monomer solutions can be found in the ESI
Chem. Sci., 2016, 7, 2207–2216 | 2209
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View Article Onlinea clear baseline for the unfolding transition at low denaturant
concentrations, the other values are consistent with MB1-1
being the most stable, followed by MB1-4, MB1-2, with MB1-3
being the least stable. In all four cases, Gd(III) coordination and
Gd(MB1)3 assembly was found to be stabilizing. Analogous
thermal denaturation studies were monitored by CD, and show
a similar trend (see Fig. S4†).Peptide oligomerisation
Though these four peptides have been designed to assemble into
three stranded coiled coils on coordination of lanthanide ions,
this was veried experimentally by performing sedimentation
equilibration studies on 100 mM solutions of peptide monomer
in the presence of one equivalence of Gd(III) per trimer, in 10mM
HEPES buﬀer pH 7.0. A similar approach has been successfully
applied in the past to peptide assembling systems.21 Equilibrium
data yielded weight-average molar masses between 8.6 and 11.2
kDa (see Table S2†). The proportion of trimer was estimated
using the expected molar mass of the complex and monomer.
MB1-1 and MB1-4 showed a greater proportion of trimer than
MB1-2 and MB1-3, consistent with the CD results.Lanthanide binding
CD spectra show an increase in folding on addition of both
Gd(III) and Tb(III), see Fig. 2, S2 and S5,† but luminescence wasFig. 3 Emission spectra (inset) and plot upon titration of TbCl3 into 30 mM
(green) and (D) MB1-4 (red). All spectra recorded at 293 K in 10 mM HEPE
280 nm.
2210 | Chem. Sci., 2016, 7, 2207–2216subsequently employed to gain insight into the coordination
directly using Tb(III). Addition of up to one equivalence of Tb(III)
per peptide trimer, was accompanied by the appearance of
characteristic Tb(III) emission peaks at 490, 545, 585, 620, and
650 nm (see Fig. 3) following excitation of the Trp unit at
280 nm. This emission is highly sensitized compared to that for
Tb(III) in the absence of peptide. The emission enhancement in
all four cases can be attributed to sensitization by the Trp unit
on coordination to the designed Asn3Asp3 binding site, as
shown by excitation spectroscopy when the Tb(III) luminescence
signal at 545 nm is monitored (see Fig. S6†).
Plots of the integrated emission intensity over the range 530–
560 nm, as a function of Tb(III) equivalents, are shown in Fig. 3
for all four peptides. These show a sharp increase followed by
a plateau at one equivalence of Tb(III) per three strands of
peptide, consistent with formation of the designed Tb(MB1)3
species. Data ts to a 1 : 3 Tb(III):peptide monomer binding
model, see Fig. 3. Despite diﬀerences in coiled coil folding and
stability, the resulting binding constants are extremely similar
(or within error), see Table 2.
As noted previously, a decrease is not observed, but rather an
increase, in the Trp emission signal (305–450 nm) on addition
of Tb(III) to a solution of MB1-2, which we attributed to a struc-
tural change on folding and an associated change in Trp envi-
ronment.19 This behavior is mirrored by the similar MB1-3
peptide. However, for MB1-4, which shows substantiallypeptide monomer for (A) MB1-1 (blue), (B) MB1-2 (purple), (C) MB1-3
S buﬀer pH 7.0. Data ﬁt to M + 3L/ ML3 model using DynaFit. lexc ¼
This journal is © The Royal Society of Chemistry 2016
Fig. 4 Plot showing the change in tryptophan emission upon titration
of TbCl3 into 30 mM MB1-1 (blue circles), MB1-2 (purple diamonds),
MB1-3 (green squares) and MB1-4 (red triangles) peptide monomer, at
293 K in 10 mM HEPES buﬀer pH 7.0. Change in emission calculated
from integration of the emission peak (F) between 305–450 nm,
where F0 is the integration in the absence of Tb(III). lexc ¼ 280 nm.
Edge Article Chemical Science
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View Article Onlineimproved folding in the absence of Tb(III) and therefore a more
modest change on Tb(III) binding, the Trp emission signal
shows only a modest change. In complete contrast, our most
folded assembly, which shows very little change on Tb(III)
binding, MB1-1, does not show an increase in Trp emission, but
rather shows a decrease. Due to the lack of a substantial
structural change (see Fig. S5†), this decrease could be assigned
to energy transfer on sensitizing the Tb(III) emission (see Fig. 4
and S7†).
In addition to Tb(III), the Trp can also sensitize Eu(III) emis-
sion. Spectra recorded for all four peptides in the presence of
Eu(III) display characteristic Eu(III) emission proles (Fig. 5 and
S8). As for the Tb(III) spectra, the emission enhancement is
attributed to Eu(III) binding in close proximity to the Trp, and to
the designed site. The lack of any observable 5D0/
7F0 tran-
sition at 580 nm and the increased intensity of the j¼ 2 over the
j ¼ 1 emission (8.8 times larger) for all four peptides, indicateFig. 5 Emission spectra of 30 mMMB1-1 (blue), MB1-2 (purple), MB1-3
(green), MB1-4 (red) monomer peptide, and a blank (orange), in the
presence of 10 mM EuCl3, recorded at 293 K in 10 mMHEPES buﬀer pH
7.0. lexc ¼ 280 nm.
This journal is © The Royal Society of Chemistry 2016a symmetric Eu(III) site, consistent with binding to a three-fold
symmetric coiled coil.22–24
Location dependent lanthanide hydration
Though all four of our designs, MB1-1, MB1-2, MB1-3 and MB1-
4, bind lanthanide ions, as is evident from induced structural
changes on lanthanide binding, as well as sensitized Tb(III) and
Eu(III) luminescence, both the apo and metallo-peptides display
diﬀerent stabilities, ascribed to the diﬀerent location of the
binding site along the coiled coil. We, therefore, set out to
interrogate the lanthanide coordination chemistry more thor-
oughly at these four diﬀerent sites. Specically we wished to
determine if exogenous water molecules were able to coordinate
to the bound Tb(III) in any of the four Tb(MB1)3 structures.
Diﬀerences could arise due to altered peptide stabilities and
therefore increased water penetration, though more likely are
that diﬀerences in local peptide structure (fraying and
unwinding/folding) and ease of water penetration at either
termini of the coiled coil (MB1-1 and MB1-4), will have a bigger
impact on the Tb(III) hydration state.
Luminescence lifetime decay studies of the Tb(MB1)3
peptides in H2O and D2O, monitored at 545 nm, were per-
formed, and rates of decay were input into the Parker–Beeby
equation,25 in order to estimate the amount of inner sphere
water bound to the coordinated Tb(III). Despite being less folded
and stable, the Tb(MB1-3)3 complex was found to have no (0.0
0.1) inner sphere water coordinated to the bound Tb(III), see
Table 2, which is the same as we previously reported for the
similar MB1-2 analogue.19 This observation is consistent with
both of these peptides providing all nine donor atoms, as well as
binding to a site generated centrally within the hydrophobic
core of a coiled coil. However, inner sphere water was found to
be present when Tb(III) coordinates more towards the terminus
of a coiled coil, as is the case for both MB1-1 and MB1-4. The
Tb(MB1-1)3 and Tb(MB1-4)3 complexes were found to have three
(3.1  0.2) and two (1.8  0.4) inner sphere water molecules,
respectively, see Table 2.
Evaluating essential residues for lanthanide binding
Here we report a thorough and complete study which examines
all of the possible binding sites within our coiled coil, is the only
example which translates complex binding sites, with multiple
residues contributing to the rst coordination sphere, and is
the only example in which the integer number of water mole-
cules coordinated is dependent on binding site location. These
ndings are in line with a previous report which found greater
water access when a Zn(His)3 site was moved from the C- to the
N-terminus of a coiled coil, and decreased water access when
located more within the middle;14 as well as a report from which
small fractional diﬀerences in the extent of inner sphere water
can be inferred,26 and related physical properties,27 for Cd sites
along a coiled coil. However, in all of these examples, regardless
of metal site location, the same amino acid side chains
remained coordinated to themetal ion. In contrast, our ndings
suggest that either some or all of the Asp residues could be
coordinated in a monodentate, rather than a bidentate fashion,Chem. Sci., 2016, 7, 2207–2216 | 2211
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View Article Onlineor that not all Asn and Asp residues are always essential for
binding. We hypothesized that the latter may be the case in
Tb(MB1-1)3, where the Asp layer is coordinated to the Tb(III) in
a bidentate fashion, but where the Asn residues are not engaged
in Tb(III) coordination. Instead the Asn residues may form
a hydrogen bonded triangular network, aided by coiled coil
fraying and expansion at the N-terminus, thereby permanently
vacating three coordination sites which can then be populated
by three inner sphere water molecules, see Fig. 1. We therefore
set out to fully interrogate the coordination requirements of the
site for lanthanide binding, and prepared a series of related
peptides which lack the top Asn layer, but retained the lower
Asp layer, to yield CS1-1 (a N-terminal site), CS1-2 (a central site)
and CS1-4 (a C-terminal site), respectively (see Table 1).
A 30 mM solution of CS1-2 monomer is exceedingly better
folded in the absence of a lanthanide than the related MB1-2
peptide (51% compared to 21 3%), see Fig. S9B and Table S1,†
consistent with the introduction of fewer destabilizing polar
residues within the hydrophobic core. The addition of one
equivalence of Tb(III) per trimer, was accompanied by only
a small increase in folding (from 51 to 59%, see Fig. S9B†),
whereas MB1-2 shows a greater change in folding (from 20 to
57%) on formation of Gd(MB1-2)3. An analogous luminescence
study showed, that whereas on formation of Tb(MB1-2)3 we
observed notably sensitized Tb(III) luminescence (see Fig. 3B),19
only a modest increase is observed in the presence of CS1-2 (see
Fig. 6B). The latter could be consistent with non-specic Tb(III)
binding, to a combination of the Asp (located adjacent to the
Trp) and Glu residues. Similarly, Tb(III) binding has less impact
on the luminescence (Fig. 6C) and CD (Fig. S9C†) spectra of CS1-
4 compared to MB1-4. These observations would be consistent
with both the Asn and the Asp residues being important for
lanthanide binding in these two sites. Therefore, in the case of
Tb(MB1-4)3, the two water molecules are likely to coordinate to
vacant sites due to Tb(III) coordination by only some of the Asn
and Asp O-donors, see Fig. 1.
In stark contrast to both CS1-2 and CS1-4, Tb(III) binding to
CS1-1 resulted in strongly sensitized luminescence (see Fig. 6A),
consistent with retention of binding despite the lack of an Asn
layer. Data from this titration could be t to a 1 : 3 Tb(III) : CS1-1
monomer binding model, see Fig. S10,† to yield a log KTb of
4.57  0.07. Luminescence decay studies of the resultingFig. 6 Emission spectra of 30 mM (A) CS1-1, (B) CS1-2 and (C) CS1-4 mo
TbCl3 (dashed red line), recorded at 293 K in 10 mM HEPES buﬀer pH 7.
2212 | Chem. Sci., 2016, 7, 2207–2216Tb(CS1-1)3 complex were consistent with a similar inner sphere
water content (3.6  0.1) compared to the MB1-1 analogue, and
sedimentation equilibrium studies conrmed the formation of
a trimer (see Table S2†). These ndings are in agreement with
our hypothesis that the Asn residues are not essential, and are
not involved in Tb(III) coordination, in Tb(MB1-1)3, see Fig. 1.
These Ln(III) sites are likely to be dynamic and Asn residues may
to a small extent occasionally contribute to the Ln(III) coordi-
nation sphere, which may account for the, though similar,
slightly lower binding constant for CS1-1 compared to MB1-1.
Therefore, the similar binding constants obtained for Tb(III)
binding to MB1-1 and MB1-2 (see Table 2) despite fewer
proposed peptide donor ligands, we suggest to be due to
enhanced peptide self association aﬃnity, which has previously
been reported to enhance metal binding aﬃnity,28 compen-
sating for the formation of what would be expected to be a less
stable metal coordination environment, Tb(Asp)3(H2O)3. The
relationship between metal binding site aﬃnity and peptide/
protein multimer stability is a theme more widely adopted in
metallo-peptide/protein design.29
Importantly, CS1-1 has demonstrated that it is possible to
coordinate Tb(III) within a three stranded coiled coil using only
an Asp layer, which provides no more than six potential donor
oxygens. However, this is highly sensitive to the location of this
layer (even within a parallel homotrimer), and only appears to
be capable of Tb(III) coordination when located towards the
N-terminus of the coiled coil. To the best of our knowledge, this
represents the rst report of coordination chemistry require-
ments being dependent on the metal-site location (of otherwise
identical sites) along a coiled coil.Location dependent impact on MRI
We previously reported, that despite Gd(MB1-2)3, having no
inner sphere water molecules, that the relaxivity was still greater
than that for the small molecule, clinically adopted, Dotarem®
(GdDOTA), under the same experimental condition (300 MHz,
7 T).19 This, we hypothesized, to be due to a primarily outer
sphere mechanism, which likely involves a hydrogen bonding
network between outer sphere water molecules and the coiled
coil surface, reduced tumbling in solution due to the coiled
coils greater size, and proton exchange between peptide andnomer peptide, in the absence (solid blue line) and presence of 10 mM
0. lexc ¼ 280 nm.
This journal is © The Royal Society of Chemistry 2016
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View Article Onlinebulk water. Considering the diﬀerent chemistries, specically
with respect to the extent of inner sphere water, when the
location of the Gd(III) binding site is translated along the coiled
coil, we set out to evaluate their eﬃciency as MRI contrast
agents. Therefore, MR images (T1 and T2 maps) were recorded of
phantom samples containing increasing concentrations of
Gd(MB1)3 in 10 mM HEPES buﬀer pH 7.0, see Fig. S11.† The
gradient of a plot of the inverse of the T1 and T2 water relaxation
times, as a function of Gd(MB1)3 concentration, yields the
longitudinal (r1) and transverse (r2) relaxivity (mM
1 s1),
a measure of the eﬃciency of the complex to alter the relaxation
time of bulk water, see Fig. S12.†
The Gd(MB1-3)3 complex displayed comparable longitudinal
(r1 ¼ 4.0  1.0 mM1 s1) and transverse (r2 ¼ 20.9  1.0
mM1 s1) relaxivity compared to the MB1-2 analogue (r1 ¼
4.2  1.2 mM1 s1; r2 ¼ 21.3  2.6 mM1 s1), see Table 2.
These observations are consistent with similar coordination
chemistries and structures. In contrast, both the longitudinal
(r1 ¼ 7.5  4.1 mM1 s1) and transverse (r2 ¼ 37.9  4.0
mM1 s1) relaxivity of Gd(MB1-4)3 are notably larger, consis-
tent with a contribution from both an outer and inner sphere
mechanism. Not surprisingly, increasing the inner sphere water
content from two (MB1-4) to three water molecules (MB1-1)
leads to the Gd(MB1-1)3 complex being the most eﬃcient at
altering the relaxation time of bulk water (r1 ¼ 10.0  1.5
mM1 s1; r2 ¼ 89.3  16.8 mM1 s1), see Table 2.
These ndings demonstrate, that the location of the Gd(III)
binding site within the coiled coil can critically alter the relax-
ivity of the agent, by bringing into play multiple mechanisms by
which magnetization is transferred to bulk water protons. As
a result, we now have a library of complexes with longitudinal
relaxivity ranging from 4–10 mM1 s1, and transverse relax-
ivity, on which these Gd(MB1)3 complexes appear to have
a more pronounced eﬀect at 7 T, from 21–89 mM1 s1.
These large increases in relaxivity, achieved by translating
the binding site a single heptad, is unprecedented, and
complexes such as these may therefore warrant further inves-
tigation as possible MRI contrast agents, if the limitations with
respect their stability can be overcome. The goal of this work
has been to interrogate a new class of lanthanide complexes,
and to identify potential areas in which they could be applied,
such as MRI, but this report is not advocating that the gadoli-
nium complexes presented herein should nd their way into
a clinical setting.
Conclusions
This study illustrates the level of control that can now be ach-
ieved in de novo metal binding site design, by, for the rst time
demonstrating that translation of a designed lanthanide
binding site (with two layers of coordinating residues) along
a coiled coil scaﬀold, yields peptide architectures with radically
diﬀerent degrees of folding and stabilities; and more impor-
tantly, that the resulting metal coordination chemistry, and
ligand requirements, is highly dependent on the binding site
location. Harnessing this knowledge is essential for the
successful design of functional metallo peptides, whereThis journal is © The Royal Society of Chemistry 2016desirable properties can require a ne balance between protein
folding, stability and metal coordination chemistry. In this
report, we have focused on the coordination of non-biological
xeno metal ions to de novo peptide scaﬀolds, for non-biological
applications. By careful selection of binding site location, and
using the herein established design rules, we have designed
lanthanide coiled coils that may be more suitable for lumines-
cence studies (MB1-2 and MB1-3, no inner sphere water), or for
MR imaging applications (MB1-1, three inner sphere water
molecules). Notably, translating the binding site a single heptad
(ca. 10 A˚) towards the N-terminus, switches the design between
these two extremes, and leads to a four-fold increase in MRI
relaxivity. These designs which incorporate xenometals, may be
of interest as potential novel imaging agents, but more impor-
tantly, they provide a greater understanding of the importance
of binding site location and how that impacts on both protein
stability and coordination chemistry. We are therefore now one
step closer to the truly de novo design of coordination sites with
predictable properties and chemistries, for these, and currently
unforeseen applications.
Materials and methods
The following reagents were purchased from Sigma Aldrich:
GdCl3$6H2O, EuCl3$6H2O and TbCl3$6H2O. Urea ($99%
purity), xylenol orange indicator, glacial acetic acid and 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) were all
purchased from Fisher Scientic Ltd. All Fmoc protected amino
acids, dimethylformamide (DMF) and N,N,N0,N0-tetramethyl-O-
(1H-benzotriazol-1-yl)uronium hexauorophosphate (HBTU)
were purchased from Pepceuticals Ltd, Leicester. The rink
amide MBHA resin was obtained from AGTC Bioproducts Ltd,
along with diisopropylethylamine (DIPEA) and triuoroacetic
acid (TFA). All D2O was purchased from VWR and the Gd(III) and
Tb(III) standards from SCP Science, Quebec.
Peptide synthesis and purication
Peptides were synthesized on a CEM Liberty Blue automated
peptide synthesizer on rink amide MBHA resin (0.25 mmol
scale, 0.65 mmol g1), using standard Fmoc-amino acid solid-
phase peptide synthesis protocols30 and puried and charac-
terized as previously reported.31
Sample preparation
Stock solutions of GdCl3, TbCl3 and EuCl3 (1 mM) were
prepared in deionized water, and their accurate concentrations
determined spectroscopically using xylenol orange indicator
and Ln(III) standard solutions as reported by Fedeli et al.32
Peptide concentrations were determined based on the trypto-
phan absorbance at 280 nm (3280 ¼ 5690 M1 cm1) in 7 M
aqueous solutions of urea.
Circular dichroism (CD) spectroscopy
CD spectra for solutions containing 30 and 100 mMmonomer in
5 mM HEPES buﬀer pH 7.0, were recorded in a 1 mm path
length quartz cuvettes on a Jasco J-715 spectropolarimeter. TheChem. Sci., 2016, 7, 2207–2216 | 2213
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View Article Onlineobserved ellipticity in millidegrees was converted into molar
ellipticity, (Q), and is reported in units of deg dmol1 cm2. The
percentage folding, %folded, was calculated based on the theo-
retical maximum ellipticity value of 39 054 deg dmol1 cm2 at
222 nm (eqn (1)), based on reports by Scholtz et al.33
%folded ¼ ½Q222 nm  ½Qcoil½Qmax  ½Qcoil
 100 (1)
The maximum ellipticity, [Q]max, is determined from (42,
500  (1  (3/n))), where n is the number of residues in the
sequence, and [Q]coil is the ellipticity of a random coil.19 Solu-
tions of metallo coiled coils were prepared on addition of
aliquots of 1 mM stock solutions of GdCl3 or TbCl3. The
percentage folded values for the apo and metallo peptides were
calculated from an average of three repeats, and the standard
deviation reported.
Chemical unfolding data was recorded by monitoring the
ellipticity at 222 nm of a 30 mM solution of peptide monomer in
5 mM HEPES buﬀer pH 7.0 in the absence and presence of
10 mM GdCl3, as a function of urea concentration (from 0 /
6.5 M). The chemical denaturation data was t to a two-state,
folded to three monomers, equilibrium model using global
analysis nonlinear least squares tting in MATLAB as outlined
in the procedure by Buer et al.34 Thermal unfolding experiments
were recorded using a Jasco Peltier temperature accessory, over
the temperature range 20–90 C, with a temperature gradient of
0.38 C min1, whilst monitoring the signal at 222 nm.Luminescence
Emission spectra were recorded in a 1 cm path length quartz
cuvette using an Edinburgh Instruments Fluorescence FLS920
system with a 450 W xenon arc lamp and a Hamamatsu R928
photomultiplier tube. The emission monochromator was tted
with two interchangeable gratings blazed at 500 nm and 1200
nm and the data was collected using F900 spectrometer analysis
soware. Aliquots of a 1 mM stock solution of TbCl3 or EuCl3
were titrated into 30 mM peptide monomer solutions in 10 mM
HEPES buﬀer pH 7.0, and the emission prole recorded aer
20 min equilibration. Solutions were excited at 280 nm and the
emission was scanned from 305–450 nm (Trp region) or 475–
750 nm (Ln(III) region) using 305 and 455 nm long pass lters,
respectively. Spectra were corrected for instrument response
(grating/PMT) in all cases. The integration of the tryptophan
emission was measured between 305–350 nm; the Tb(III) emis-
sion integration at 545 nm was measured between 530–560 nm;
and the Eu(III) emission integration at 591 and 616 nm were
measured between 581–598 nm, and 605–629 nm, respectively.
The Tb(III) emission integration data was t using DynaFit
Soware (Biokin Ltd, Massachusetts)35 with a M + 3L / ML3
(K1) binding equation to determine the binding constant. This
was converted to a rst order binding constant based on 13M + L
/ 13(ML3) (K), where K ¼
ﬃﬃﬃﬃﬃ
K13
p
. The model included a variable
monomer concentration to account for any errors in sample
preparation, and led to values of 27.5, 25.0, 29.0 and 27.8 mM for
MB1-1, MB1-2, MB1-3 and MB1-4, respectively.2214 | Chem. Sci., 2016, 7, 2207–2216Tb(III) lifetimes in D2O and H2O were determined for all
Tb-peptide complexes by monitoring solutions containing
10 mM Tb(III) and 100 mM monomer peptide (to ensure >99% of
the Tb(III) is bound) in 10 mM HEPES buﬀer pH 7.0 using a mF
ash lamp light source (50 Hz) on an Edinburgh Instruments
spectrouorimeter, collecting over a 10 ms time range, with
a lamp trigger delay of 0.1 ms. The peptide samples were
deuterated by equilibration in 99.9% D2O for 8 hours prior to
lyophilisation. This process was repeated and then the lifetime
of the deuterated samples recorded in 99.96% D2O. Data was
tted to mono-exponential decay kinetics in Kaleidagraph using
the Marquardt–Levenberg linear least squares algorithm, and
from the observed lifetime the number of coordinated water
molecules was determined using the Parker–Beeby equation.25
The absorption spectra of the excitation samples were recorded
on a Shimadzu AP-120 photometer between 200 and 400 nm.NMR spectroscopy
Data was collected on a Bruker DMX 300 spectrometer equipped
with a 7 T vertical wide-bore superconducting magnet operating
at a proton resonance frequency of 300.13 MHz with a 30 mm
RF bird cage coil. The spectrometer was controlled by a Linux
workstation operating TOPSPIN version 1.3 and ParaVision
version 3.0 soware. All experiments were recorded at 293 K and
the 90 and 180 radiofrequency pulses were calibrated for each
sample. T1 and T2 maps of water protons in phantom samples
prepared in 5 mm NMR tubes were acquired using a RARE
(Rapid Acquisition with Relaxation Enhancement) spin-echo
imaging sequence. Horizontal images were acquired with
a 1 mm slice thickness, using a 25  25 mm eld-of-view and
a 64  64 pixel matrix. A repetition time of TR ¼ 16 s was used.
T1 relaxation maps were produced from a series of 9 spin echo
images with varying T1 inversion recovery delays from 2.2–
15 000 ms and RARE factor of 8. T2 relaxation maps were
produced from 128 echo images with echo times from 10–
1280 ms and a RARE factor of 1. All imaging experiments were
performed in triplicate and were analyzed using Prospa so-
ware (Magritek, Wellington, New Zealand), where the relaxation
time for each concentration was taken from the average value
from the pixels within the sample. The values for T2 were cor-
rected for eﬀects of signal loss from diﬀusion during the
imaging sequences (see ESI for details†). The relaxivity
(mM1 s1) was calculated from the gradient of a plot of the
average 1/T(1,2) against the GdCl3 concentration. The relaxivity
of Gd(MB1-1)3, Gd(MB1-2)3, Gd(MB1-3)3 and Gd(MB1-4)3 was
determined from solutions containing 20, 30 and 40 mM GdCl3
and 6 equivalences of peptide monomer, prepared in 10 mM
HEPES pH 7.0. Additional samples of 10 mM pH 7.0 HEPES and
0.1 mM GdCl3 were included as controls.
The excess of peptide (6 monomers per Gd(III)) was used to
ensure that >99% of Gd(III) was bound at the lowest concen-
tration (20 mM). Based on the lowest binding constant deter-
mined (vide supra) (log K ¼ 5.16), we would predict that 99% of
the Gd(III) is bound in the presence of two equivalences of
trimer, and that this increases to 99.9% upon addition of the
third equivalence of trimer. Addition of a third equivalence wasThis journal is © The Royal Society of Chemistry 2016
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View Article Onlinefound to have no notable change at 10 mM Gd(III) (see Fig. S11
and Table S3†).Sedimentation equilibrium
Samples were analysed using a Beckman Optima XL-I Analytical
Ultracentrifuge at 45 000 rpm (150 000  g). Equal volumes of
buﬀer and peptide solution (100 mM monomer and 1/3 equiv-
alence of GdCl3) at 0.7 AU were loaded into cells constructed
with 12 mm path length, aluminum epoxy centerpieces and
sapphire windows. Absorbance optics at 280 nm were employed
and scans performed every hour to observe the approach to
equilibrium. Scans were acquired and logged using Proteome
Soware v6 (Beckman, Palo Alto, CA). Once all samples were
conrmed to have reached equilibrium, ve scans were ob-
tained in succession.
These nal ve scans were averaged and analyzed using
SEDFIT-MSTAR.36 Apparent, weight-average molar masses were
obtained through the M* function of Creeth and Harding,37
combined with the c(M) method of Schuck et al.35 to nd the
meniscus concentration and baseline. These values were
assumed to be free from non-ideality due to the low concen-
tration and low monomer molar mass.36Acknowledgements
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